Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model, Application, End Users, and Region

Description

List of Tables

The digital therapeutics market size is expected to reach USD 70.63 billion by 2032, according to a new study by Polaris Market Research. The report "Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model (Subscription and Value-Based), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The digital therapeutics market growth is driven by increasing internet access globally in developed as well as developing countries. For instance, according to statistics of Our World in Data, in 2000, 7% of the Asian population had access to the internet, while just 3% of the African region was online. By 2016, the population share with internet access increased significantly, with 91% of the population in South Korea and Japan having internet access and 97% of the population in Denmark and Norway online. After six years, in 2022, major regions of Africa witnessed 81% of the population share gain internet access.

Government initiatives and incentives in order to digitalize the whole ecosystem are anticipated to boost the digital therapeutics market during the forecast years. Increased government funding in the healthcare sector and the introduction of schemes for the digitalization of the healthcare sector are expected to fuel the digital therapeutics market during the study time. For instance, in August 2023, the government of India introduced the Digital Health Incentive Scheme (DHIS) under the Ayushman Bharat Digital Mission (ABDM) to encourage the adoption of digital health, laboratories, and health tech companies. In the digital health incentive scheme, new health tech startups will be offered incentives up to 4 crore INR.

Employers and patients are the major consumers of digital therapeutic services. Major companies have started adding therapies as services in their employee packages, providing lifestyle management, depression, and hypertension-related services. Patients with chronic diseases, such as diabetes and cardiovascular diseases, can use the services for day-to-day consultation.

Digital Therapeutics Market Report Highlights

By revenue model analysis, the subscription segment is anticipated to experience substantial growth in the global market. This growth is attributed to major advantages that are associated with the subscription-based revenue model.

By end users analysis, the employers segment is anticipated to dominate the market from 2024 to 2032 due to major companies globally having started including digital therapeutics packages in their services.

In 2023, North America dominated the digital therapeutics market due to the large share of the population having internet access and increasing digitalization.

The digital therapeutics market in India is projected for substantial growth due to the regulatory support and initiatives for the digitalization of the healthcare sector.

The key market players are Proteus Digital Health, Inc.; Fitbit, Inc.; Pear Therapeutics, Inc.; Kaia Health; Happify, Inc.; Medtronic Plc.; Omada Health, Inc.; Livongo Health, Inc.; Voluntis Inc.; Resmed, Inc.; Welldoc, Inc.; 2Morrow Inc.; Canary Health; and Mindable Health GmbH.

Polaris Market Research has segmented the digital therapeutics market report based on revenue model, application, end users, and region:

By Revenue Model Outlook (Revenue - USD billion, 2019-2032)

Subscription
Value-based
One Time Purchase

By Application Outlook (Revenue - USD billion, 2019-2032)

Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Lifestyle Management
Preventive Applications
Others

By End Users Outlook (Revenue - USD billion, 2019-2032)

Patients
Providers
Payers
Employers
Others

By Regional Outlook (Revenue - USD billion, 2019-2032)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of the Middle East & Africa

Product Code: PM1908

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Digital Therapeutics Market Insights

4.1. Digital Therapeutics Market - Market Snapshot
4.2. Digital Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancements in Service Oriented Software Are Driving Market Growth
  - 4.2.1.2. Increase in Daily Hours Spend on Internet is Propelling Market Size
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of Capital Investment
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Digital Therapeutics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Digital Therapeutics Market, by Revenue Model

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
5.3. Subscription
- 5.3.1. Global Digital Therapeutics Market, by Subscription, by Region, 2019-2032 (USD billion)
5.4. Value Based
- 5.4.1. Global Digital Therapeutics Market, by Value Based, by Region, 2019-2032 (USD billion)
5.5. One Time Purchase
- 5.5.1. Global Digital Therapeutics Market, by One Time Purchase, by Region, 2019-2032 (USD billion)

6. Global Digital Therapeutics Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
6.3. Diabetes
- 6.3.1. Global Digital Therapeutics Market, by Diabetes, by Region, 2019-2032 (USD billion)
6.4. Obesity
- 6.4.1. Global Digital Therapeutics Market, by Obesity, by Region, 2019-2032 (USD billion)
6.5. CVD
- 6.5.1. Global Digital Therapeutics Market, by CVD, by Region, 2019-2032 (USD billion)
6.6. CNS Disease
- 6.6.1. Global Digital Therapeutics Market, by CNS Disease, by Region, 2019-2032 (USD billion)
6.7. Respiratory Disease
- 6.7.1. Global Digital Therapeutics Market, by CVD, by Respiratory Disease, 2019-2032 (USD billion)
6.8. Smoking Cessation
- 6.8.1. Global Digital Therapeutics Market, by Smoking Cessation, by Region, 2019-2032 (USD billion)
6.9. Lifestyle Management
- 6.9.1. Global Digital Therapeutics Market, by Lifestyle Management, by Region, 2019-2032 (USD billion)
6.10. Preventive Applications
- 6.10.1. Global Digital Therapeutics Market, by Preventive Applications, by Region, 2019-2032 (USD billion)
6.11. Others
- 6.11.1. Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

7. Global Digital Therapeutics Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
7.3. Patients
- 7.3.1. Global Digital Therapeutics Market, by Patients, by Region, 2019-2032 (USD billion)
  - 7.3.1.1.
7.4. Providers
- 7.4.1. Global Digital Therapeutics Market, by Providers, by Region, 2019-2032 (USD billion)
7.5. Payers
- 7.5.1. Global Digital Therapeutics Market, by Payers, by Region, 2019-2032 (USD billion)
7.6. Employers

Global Digital Therapeutics Market, by Employers, by Region, 2019-2032 (USD billion)

7.7. Others

Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

8. Global Digital Therapeutics Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Digital Therapeutics Market Assessment, By Geography, 2019-2032 (USD billion)
8.3. Digital Therapeutics Market - North America
- 8.3.1. North America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.3.2. North America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.3.3. North America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.3.4. Digital Therapeutics Market - U.S.
  - 8.3.4.1. U.S.: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.3.4.2. U.S.: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.3.4.3. U.S.: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.3.5. Digital Therapeutics Market - Canada
  - 8.3.5.1. Canada: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.3.5.2. Canada: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.3.5.3. Canada: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
8.4. Digital Therapeutics Market - Europe
- 8.4.1. Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.4.2. Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.4.3. Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.4. Digital Therapeutics Market - UK
  - 8.4.4.1. UK: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.4.2. UK: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.4.3. UK: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.5. Digital Therapeutics Market - France
  - 8.4.5.1. France: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.5.2. France: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.5.3. France: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.6. Digital Therapeutics Market - Germany
  - 8.4.6.1. Germany: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.6.2. Germany: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.6.3. Germany: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.7. Digital Therapeutics Market - Italy
  - 8.4.7.1. Italy: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.7.2. Italy: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.7.3. Italy: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.8. Digital Therapeutics Market - Spain
  - 8.4.8.1. Spain: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.8.2. Spain: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.8.3. Spain: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.9. Digital Therapeutics Market - Netherlands
  - 8.4.9.1. Netherlands: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.9.2. Netherlands: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.9.3. Netherlands: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.10. Digital Therapeutics Market - Russia
  - 8.4.10.1. Russia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.10.2. Russia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.10.3. Russia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.11. Digital Therapeutics Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.11.2. Rest of Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.11.3. Rest of Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
8.5. Digital Therapeutics Market - Asia Pacific
- 8.5.1. Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.5.2. Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.5.3. Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.4. Digital Therapeutics Market - China
  - 8.5.4.1. China: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.4.2. China: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.4.3. China: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.5. Digital Therapeutics Market - India
  - 8.5.5.1. India: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.5.2. India: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.5.3. India: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.6. Digital Therapeutics Market - Malaysia
  - 8.5.6.1. Malaysia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.6.2. Malaysia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.6.3. Malaysia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.7. Digital Therapeutics Market - Japan
  - 8.5.7.1. Japan: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.7.2. Japan: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.7.3. Japan: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.8. Digital Therapeutics Market - Indonesia
  - 8.5.8.1. Indonesia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.8.2. Indonesia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.8.3. Indonesia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.9. Digital Therapeutics Market - South Korea
  - 8.5.9.1. South Korea: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.9.2. South Korea: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.9.3. South Korea: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.10. Digital Therapeutics Market - Australia
  - 8.5.10.1. Australia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.10.2. Australia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.10.3. Australia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.11. Digital Therapeutics Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.11.2. Rest of Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.11.3. Rest of Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
8.6. Digital Therapeutics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.6.2. Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.6.3. Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.4. Digital Therapeutics Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.4.2. Saudi Arabia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.4.3. Saudi Arabia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.5. Digital Therapeutics Market - UAE
  - 8.6.5.1. UAE: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.5.2. UAE: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.5.3. UAE: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.6. Digital Therapeutics Market - Israel
  - 8.6.6.1. Israel: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.6.2. Israel: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.6.3. Israel: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.7. Digital Therapeutics Market - South Africa
  - 8.6.7.1. South Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.7.2. South Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.7.3. South Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.8. Digital Therapeutics Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.8.2. Rest of Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.8.3. Rest of Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
8.7. Digital Therapeutics Market - Latin America
- 8.7.1. Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.7.2. Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.7.3. Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.7.4. Digital Therapeutics Market - Mexico
  - 8.7.4.1. Mexico: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.7.4.2. Mexico: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.7.4.3. Mexico: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.7.5. Digital Therapeutics Market - Brazil
  - 8.7.5.1. Brazil: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.7.5.2. Brazil: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.7.5.3. Brazil: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.7.6. Digital Therapeutics Market - Argentina
  - 8.7.6.1. Argentina: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.7.6.2. Argentina: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.7.6.3. Argentina: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.7.7. Digital Therapeutics Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.7.7.2. Rest of Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.7.7.3. Rest of Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Proteus Digital Health, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Fitbit Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Pear Therapeutics, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Kaia Health
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Happify, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Medtronic Plc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Omada Health, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Livongo Health, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Voluntis, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Resmed, Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Welldoc, Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. 2Morrow Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Canary Health
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Mindable Health GmbH.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development